Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
Frequently asked questions
What sector does Genus plc (GENSF) operate in?
Genus plc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Genus plc (GENSF) current stock price?
As of the latest data, Genus plc stock price is $28.14, with a previous close of $28.14.
What is Genus plc (GENSF) current market capitalization?
Genus plc market cap is approximately 1.84 billion.
What is Genus plc (GENSF) Earnings Per Share (EPS)?
The trailing EPS is $5.70.
What is Genus plc (GENSF) Price-to-Earnings (P/E) ratio?
Genus plc current P/E ratio is 4.94.
What is Genus plc (GENSF) EBITDA?
Genus plc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 63.92 million.
Does Genus plc (GENSF) pay dividends?
Yes. Genus plc pays semiannual dividends with an annualized yield of 2.83% and an estimated annual payout of $0.80 per share.
When is the next ex-dividend date for Genus plc (GENSF)?
The next ex-dividend date is scheduled for November 13, 2026.
What is Genus plc (GENSF) beta (volatility) score?
Genus plc has a beta of 0.905, meaning its volatility is roughly in line with the market.